These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 17085376

  • 1. The long-term effects of low-dose 17beta-estradiol and dydrogesterone hormone replacement therapy on 24-h ambulatory blood pressure in hypertensive postmenopausal women: a 1-year randomized, prospective study.
    Kaya C, Dinçer Cengiz S, Cengiz B, Akgün G.
    Climacteric; 2006 Dec; 9(6):437-45. PubMed ID: 17085376
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects of low-dose 17beta-estradiol plus dydrogesterone on 24-h ambulatory blood pressure in healthy postmenopausal women: a 1-year, randomized, prospective study.
    Kaya C, Cengiz SD, Cengiz B, Akgun G.
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():62-7. PubMed ID: 17943541
    [Abstract] [Full Text] [Related]

  • 3. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women.
    Cacciatore B, Paakkari I, Hasselblatt R, Nieminen MS, Toivonen J, Tikkanen MI, Ylikorkala O.
    Am J Obstet Gynecol; 2001 Apr; 184(5):904-9. PubMed ID: 11303197
    [Abstract] [Full Text] [Related]

  • 4. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S, Mercuri A, Prontera C, Zucchelli GC, Vassalle C.
    Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
    [Abstract] [Full Text] [Related]

  • 5. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension.
    Kawecka-Jaszcz K, Czarnecka D, Olszanecka A, Rajzer M, Jankowski P.
    J Hum Hypertens; 2002 Jul; 16(7):509-16. PubMed ID: 12080436
    [Abstract] [Full Text] [Related]

  • 6. Effects of 15 months of 17 beta-estradiol and dydrogesterone on systolic cardiac function according to quantitative and Doppler echocardiography in healthy postmenopausal women.
    Kessel H, Kamp O, Kenemans P, Mijatovic V, van Baal WM, Visser CA, van der Mooren MJ.
    Am J Obstet Gynecol; 2001 Apr; 184(5):910-6. PubMed ID: 11303198
    [Abstract] [Full Text] [Related]

  • 7. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
    Oelkers WH.
    Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652
    [Abstract] [Full Text] [Related]

  • 8. The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension.
    Czarnecka D, Kawecka-Jaszcz K, Olszanecka A, Dembińska-Kieć A, Malczewska-Malec M, Zdzienicka A, Guevara I.
    Med Sci Monit; 2004 Feb; 10(2):CR55-61. PubMed ID: 14737044
    [Abstract] [Full Text] [Related]

  • 9. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
    Chiantera V, Sarti CD, Fornaro F, Farzati A, De Franciscis P, Sepe E, Borrelli AL, Colacurci N.
    Menopause; 2003 Feb; 10(4):286-91. PubMed ID: 12851511
    [Abstract] [Full Text] [Related]

  • 10. Effect of different hormone replacement therapy regimens on circadian blood pressure profile and active renin in postmenopausal women.
    Zacharieva S, Kirilov G, Kalinov K, Shigarminova R, Nachev E, Orbetzova M, Atanassova I.
    Gynecol Endocrinol; 2002 Dec; 16(6):461-7. PubMed ID: 12626033
    [Abstract] [Full Text] [Related]

  • 11. Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial.
    Steiner AZ, Hodis HN, Lobo RA, Shoupe D, Xiang M, Mack WJ.
    Menopause; 2005 Dec; 12(6):728-33. PubMed ID: 16278616
    [Abstract] [Full Text] [Related]

  • 12. One year follow-up of hormone replacement therapy with percutaneous estradiol and low-dose vaginal natural progesterone in women with mild to moderate hypertension.
    Spritzer PM, Vitola D, Vilodre LC, Wender MC, Reis FM, Ruschel S, Castro I.
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):267-73. PubMed ID: 12951632
    [Abstract] [Full Text] [Related]

  • 13. Effect of transdermal estrogen therapy on some vasoactive humoral factors and 24-h ambulatory blood pressure in normotensive postmenopausal women.
    Zacharieva S, Atanassova I, Kirilov G, Kalinov K, Shigarminova R, Nachev E, Aslanova N.
    Climacteric; 2002 Sep; 5(3):293-9. PubMed ID: 12419088
    [Abstract] [Full Text] [Related]

  • 14. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide.
    Preston RA, Norris PM, Alonso AB, Ni P, Hanes V, Karara AH.
    Menopause; 2007 Sep; 14(3 Pt 1):408-14. PubMed ID: 17224857
    [Abstract] [Full Text] [Related]

  • 15. Low-dose transdermal hormone therapy does not interfere with the blood pressure of hypertensive menopausal women: a pilot study.
    de Carvalho MN, Nobre F, Mendes MC, Dos Reis RM, Ferriani RA, Silva de Sá MF.
    Blood Press Monit; 2008 Oct; 13(5):277-83. PubMed ID: 18799953
    [Abstract] [Full Text] [Related]

  • 16. 1 and 2 mg 17beta-estradiol combined with sequential dydrogesterone have similar effects on the serum lipid profile of postmenopausal women.
    Stevenson JC, Rioux JE, Komer L, Gelfand M.
    Climacteric; 2005 Dec; 8(4):352-9. PubMed ID: 16390770
    [Abstract] [Full Text] [Related]

  • 17. Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin- aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women.
    Ichikawa A, Sumino H, Ogawa T, Ichikawa S, Nitta K.
    Geriatr Gerontol Int; 2008 Dec; 8(4):259-64. PubMed ID: 19149837
    [Abstract] [Full Text] [Related]

  • 18. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 19. [A Brazilian multicenter study to evaluate the clinical effectiveness and tolerance of isradipine SRO using ambulatory monitoring of arterial pressure in the treatment of mild and moderate arterial hypertension].
    Magliano MF, Amodeo C, Mion Júnior D, Francischetti E, Lima Júnior E, Nobre F, Chaves H, Ribeiro JM, Spritzer N, Jardim PC.
    Arq Bras Cardiol; 1993 Nov; 61(5):311-8. PubMed ID: 8147731
    [Abstract] [Full Text] [Related]

  • 20. [Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study].
    Grisar J, Travica S, Metka M, Pietschmann P.
    Wien Klin Wochenschr; 1999 Dec 23; 111(24):1035-43. PubMed ID: 10677891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.